Overcoming resistance to endocrine therapy in hormone receptor-positive human epidermal growth factor receptor 2-negative (HR / 医学前沿
Frontiers of Medicine
;
(4): 208-220, 2021.
Article
in English
| WPRIM
| ID: wpr-880965
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Receptors, Estrogen
/
Randomized Controlled Trials as Topic
/
Receptor, ErbB-2
/
Hormones
Type of study:
Controlled clinical trial
Limits:
Humans
Language:
English
Journal:
Frontiers of Medicine
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS